title: Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study.
abstract: OBJECTIVE
  To evaluate the demographic characteristics, clinical course, and outcome in organ transplant recipients with metastatic skin cancer.
  
  
  METHODS
  An international, multicenter, Internet-coordinated collaborative group retrospectively analyzed data from 68 organ transplant recipients with 73 distinct metastatic skin cancers.
  
  
  METHODS
  The Kaplan-Meier method was used to estimate the cumulative incidence of relapse, overall survival, and disease-specific survival after metastatic skin cancer. Univariate Cox proportional hazards models were fit to evaluate factors for an association with survival.
  
  
  RESULTS
  Metastasis from skin cancer in organ transplant recipients most commonly consisted of squamous cell carcinoma in regional nodal basins. It was predominantly treated with a combination of surgery and irradiation. By 1 year after metastasis, the cumulative incidence of relapse was 29%, and the 3-year disease-specific survival was 56%. Patients whose initial metastases were distant or systemic had a significantly poorer disease-specific survival than those whose initial metastases were in-transit or regional (risk ratio, 6.5; P<.001).
  
  
  CONCLUSIONS
  Metastatic skin cancer in organ transplant recipients has a poor prognosis. Preventive, early, and aggressive therapeutic interventions are required to minimize this serious complication of transplant-associated immunosuppression.
authors.affiliation: Mayo Medical School, Rochester, MN, USA.
authors.forename: Juan-Carlos
authors.initials: JC
authors.lastname: Martinez
authors.forename: Clark C
authors.initials: CC
authors.lastname: Otley
authors.forename: Thomas
authors.initials: T
authors.lastname: Stasko
authors.forename: Sylvie
authors.initials: S
authors.lastname: Euvrard
authors.forename: Christine
authors.initials: C
authors.lastname: Brown
authors.forename: Carl F
authors.initials: CF
authors.lastname: Schanbacher
authors.forename: Amy L
authors.initials: AL
authors.lastname: Weaver
mesh_terms: D000328:Adult; D015266:Carcinoma, Merkel Cell / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology* / Q000209:etiology / Q000401:mortality / Q000556:secondary; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D015994:Incidence; D008207:Lymphatic Metastasis; D008297:Male; D008499:Medical Records; D008545:Melanoma / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000556:secondary; D016377:Organ Transplantation; D011379:Prognosis; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000453:epidemiology* / Q000209:etiology / Q000401:mortality / Q000473:pathology; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology